Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saroj Niraula

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Broadening horizons in medical management of prostate cancerSaroj Niraula, Ian F Tannock
Breast (Edinburgh, Scotland)|June 27, 2015
One step forward, two steps back: The story of everolimus in advanced breast cancerSaroj Niraula, Alberto Ocana, Eitan Amir
JNCI Cancer Spectrum|August 19, 2021
Feasibility of Randomized Controlled Trials for Cancer Drugs Approved by the Food and Drug Administration Based on Single-Arm StudiesRebekah Rittberg, Piotr Czaykowski, Saroj Niraula
Hormones & Cancer|November 30, 2011
Beyond castration-defining future directions in the hormonal treatment of prostate cancerSaroj Niraula, Kim Chi, Anthony Michael Joshua
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Treatment of prostate cancer with intermittent versus continuous androgen deprivation: a systematic review of randomized trialsSaroj Niraula, Lisa W Le, Ian F Tannock
Breast Cancer Research and Treatment|May 8, 2012
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysisSaroj Niraula, Alberto Ocana, Marguerite Ennis, et al.
Journal of the National Cancer Institute|July 12, 2011
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysisEitan Amir, Bostjan Seruga, Saroj Niraula, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2026
Conflicts of interest and interpretive authority in oncologySaroj Niraula, Samuel X Stevens, Tito Fojo, et al.
JAMA Network Open|September 25, 2020
Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast CancersSaroj Niraula, Natalie Biswanger, PingZhao Hu, et al.
Journal of Molecular Endocrinology|February 23, 2012
Metformin in cancer: translational challengesRyan J O Dowling, Saroj Niraula, Vuk Stambolic, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Acta Oncologica (Stockholm, Sweden)|May 25, 2011
Broadening horizons in medical management of prostate cancerSaroj Niraula, Ian F Tannock
Breast (Edinburgh, Scotland)|June 27, 2015
One step forward, two steps back: The story of everolimus in advanced breast cancerSaroj Niraula, Alberto Ocana, Eitan Amir
JNCI Cancer Spectrum|August 19, 2021
Feasibility of Randomized Controlled Trials for Cancer Drugs Approved by the Food and Drug Administration Based on Single-Arm StudiesRebekah Rittberg, Piotr Czaykowski, Saroj Niraula
Hormones & Cancer|November 30, 2011
Beyond castration-defining future directions in the hormonal treatment of prostate cancerSaroj Niraula, Kim Chi, Anthony Michael Joshua
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Treatment of prostate cancer with intermittent versus continuous androgen deprivation: a systematic review of randomized trialsSaroj Niraula, Lisa W Le, Ian F Tannock
Breast Cancer Research and Treatment|May 8, 2012
Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysisSaroj Niraula, Alberto Ocana, Marguerite Ennis, et al.
Journal of the National Cancer Institute|July 12, 2011
Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysisEitan Amir, Bostjan Seruga, Saroj Niraula, et al.
European Journal of Cancer (Oxford, England : 1990)|June 1, 2026
Conflicts of interest and interpretive authority in oncologySaroj Niraula, Samuel X Stevens, Tito Fojo, et al.
JAMA Network Open|September 25, 2020
Incidence, Characteristics, and Outcomes of Interval Breast Cancers Compared With Screening-Detected Breast CancersSaroj Niraula, Natalie Biswanger, PingZhao Hu, et al.
Journal of Molecular Endocrinology|February 23, 2012
Metformin in cancer: translational challengesRyan J O Dowling, Saroj Niraula, Vuk Stambolic, et al.
Pageof 4